EVOK - MA200 Holding - Momentum Increasing

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.

SHORT INTEREST
585.77K 09/13/19

P/E Current
-1.80

P/E Ratio (with extraordinary items)
-2.60

Average Recommendation: HOLD

Average Target Price: 9.00